MiniMed Group Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Quarter	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025
Period Ending	Apr '26 Apr 24, 2026	Jan '26 Jan 23, 2026	Oct '25 Oct 24, 2025	Jul '25 Jul 24, 2025	Apr '25 Apr 25, 2025	Jan '25 Jan 24, 2025	Oct '24 Oct 25, 2024	Jul '24 Jul 25, 2024
Net Income	-185	-111	-10.5	-10.5	-168	-7	-11.5	-11.5
Depreciation & Amortization	39	39	39	39	38	37	34	34
Stock-Based Compensation	8	12	13	13	9	10	11	11
Other Adjustments	-45	20	12	12	9	8	7.5	7.5
Change in Receivables	11	-74	-10	-10	-30	-20	-8	-8
Changes in Inventories	64	-43	-25	-25	22	-26	-7.5	-7.5
Changes in Accounts Payable	67	126	-76	-76	187	35	-15.5	-15.5
Changes in Other Operating Activities	31	13	11	11	15	-13	7	7
Operating Cash Flow	-170	66	-46.5	-46.5	83	24	16.5	16.5
Operating Cash Flow Growth	-	175.00%	-	-	-	-	-	-
Capital Expenditures	-56	-53	-57	-57	-57	-50	-43	-43
Other Investing Activities	0	0	-5	-5	-	-	-	-
Investing Cash Flow	-56	-53	-62	-62	-57	-50	-43	-43
Other Financing Activities	203	-11	107.5	107.5	-25	28	4.5	4.5
Financing Cash Flow	512	-11	107.5	107.5	-25	25	5	5
Net Cash Flow	287	2	-1	-1	1	0	-22	-22
Free Cash Flow	-226	13	-103.5	-103.5	26	-26	-26.5	-26.5
FCF Margin	-27.00%	1.65%	-14.03%	-14.03%	3.59%	-3.78%	-4.06%	-4.06%
Free Cash Flow Per Share	-0.84	0.05	-0.41	-0.41	0.10	-0.10	-	-
Levered Free Cash Flow	-40	-37	-122.5	-122.5	33	-27	-40.5	-40.5
Unlevered Free Cash Flow	-42.01	-30.12	-123.75	-123.75	36	-24	-36.5	-36.5

SEC Filings: 10-K · 10-Q